Volume 3, Number 2—June 1997
Synopsis
Rhodococcus equi and Arcanobacterium haemolyticum: Two "Coryneform" Bacteria Increasingly Recognized as Agents of Human Infection
Regina Linder
Table 2
Representative pharyngitis screenings for Arcanobacterium haemolyticum
| Period of study (reference) | Number of isolations | Rash | Coinfection | Incidencea (%) | Clinical features (population) |
|---|---|---|---|---|---|
| 1978-80 (16) | 16 | 0 | 13 (C. diphtheriae, S . pyogenes, E. coli, P. aeruginosa) | NR | Symptomatic throat swabs and pyoderma (Sri Lanka) |
| 1981-85 (19) | 81b | 37 | NR | 2.0 | Symptomatic throat swabs (Sweden) |
| 1990-92 (17) | 42 | 17 | NR | 0.36 | Symptomatic throat swabs; 5 cases onospot positive (Ottawa, Canada) |
| 1991-92 (42) | 19 | 5 | 11 (streptococci, groups A, B, G) | 0.49 | Symptomatic throat swabs, 3922c; (Finland) |
| 1992-95 (43) | 16 | 12 | 5 (streptococci, groups A, B, ß-hemolytic) | 0.75 | Symptomatic throat swabs, 2121c; (Czech Republic) |
NR-not reported
a Incidence refers to the proportion of sore throat cases in each study cited yielding A. haemolyticum.
b1 of 550 asymptomatic specimens yielded A. haemolyticum.
cFigures refer to the total specimens screened.
